Navigation Links
Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
Date:4/9/2008

SOUTH SAN FRANCISCO, Calif., April 9, 2008 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that data from a Phase 2 trial of picoplatin, the Company's lead product candidate, in patients with small cell lung cancer (SCLC) will be presented in a poster session at the 1st European Lung Cancer Conference in Geneva, Switzerland. The presentation is the first European presentation of data from the Phase 2 trial. The Conference is sponsored by the International Association for the Study of Lung Cancer (IASLC) and the European Society for Medical Oncology (ESMO). Details are as follows:

-- Abstract #143

A Phase 2 study of picoplatin monotherapy in patients with platinum

refractory/resistant small cell lung cancer (SCLC)

Bentzion D, Lipatov O, Poliakov I, MacKintosh R, Breitz H. Eckardt J

Poster Session: SCLC: On display from 2:00 p.m. Wednesday, April 23,

through 12:30 p.m. Saturday, April 26

Geneva Palexpo Foyer Level 1

Presented by: John R. Eckardt, M.D., Center for Cancer Care Research,

Saint Louis, MO.

About Picoplatin

Picoplatin is a chemotherapeutic agent that has an improved safety profile compared to existing platinum-based chemotherapeutics. It was designed to overcome platinum resistance associated with the treatment of solid tumors. Picoplatin has been evaluated in more than 750 patients and has anti-tumor activity in multiple indications with less severe kidney or nerve toxicity than is commonly observed with other platinum chemotherapy drugs.

Poniard is evaluating intravenous picoplatin in an ongoing pivotal Phase 3 trial, known as
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
2. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
3. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
4. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
7. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
8. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
11. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Los beneficios y ganancias están por ... gasto en investigación y desarrollo   En ... septiembre de 2014) ZEISS aumentó sus ingresos en un ... anterior: 4.190 millones de euros) a pesar de los ... un 14 por ciento, a 360 millones de euros. ...
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... Dec. 17, 2014 With advancements in ... MRI market is seeing new growth, according to ... scans account for the majority of market volume, ... of images, which are creating opportunities for more sophisticated ... is growing at a rate of 4%, with ...
Breaking Medicine Technology:ZEISS confirma su posición en un entorno difícil 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... 2010 Bayer HealthCare Pharmaceuticals, Inc. today announced the ... new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl ... levomefolate calcium 451 mcg tablets).  In women who choose ... for the purpose of reducing the risk of rare ...
... LAS VEGAS, Dec. 16, 2010 American Pacific Corporation (Nasdaq: ... fiscal 2010 year and fourth quarter ended September 30, 2010. ... to financial results based on GAAP.  A reconciliation of the ... included in the accompanying supplemental data. ...
Cached Medicine Technology:U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 2U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 3U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 4U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 5U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 6U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 7U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels 8American Pacific Reports Fiscal 2010 Results 2American Pacific Reports Fiscal 2010 Results 3American Pacific Reports Fiscal 2010 Results 4American Pacific Reports Fiscal 2010 Results 5American Pacific Reports Fiscal 2010 Results 6American Pacific Reports Fiscal 2010 Results 7American Pacific Reports Fiscal 2010 Results 8American Pacific Reports Fiscal 2010 Results 9American Pacific Reports Fiscal 2010 Results 10American Pacific Reports Fiscal 2010 Results 11American Pacific Reports Fiscal 2010 Results 12American Pacific Reports Fiscal 2010 Results 13American Pacific Reports Fiscal 2010 Results 14American Pacific Reports Fiscal 2010 Results 15American Pacific Reports Fiscal 2010 Results 16American Pacific Reports Fiscal 2010 Results 17American Pacific Reports Fiscal 2010 Results 18American Pacific Reports Fiscal 2010 Results 19American Pacific Reports Fiscal 2010 Results 20American Pacific Reports Fiscal 2010 Results 21American Pacific Reports Fiscal 2010 Results 22American Pacific Reports Fiscal 2010 Results 23
(Date:12/20/2014)... New York (PRWEB) December 20, 2014 ... continue to move forward in U.S. courts, Bernstein ... study which suggests that children treated with the ... hormone linked to breast development and lactation. The ... at 34 children and adolescents who began treatment ...
(Date:12/20/2014)... Recently, AngelWeddingDress.com has introduced its special offer (called the ... In the promotion, all buyers worldwide can enjoy a ... special for the women who are looking for inspired, ... collections of 2015 dresses have been unveiled recently. All ... prices. Visit our website now before they are out ...
(Date:12/20/2014)... The Twin Cities DI Day is ... the nation! Over 250 financial professionals come together each ... the industry, get motivated to protect their clients and ... and overcoming the challenges of disability. , On September ... came together to attend The 13th Annual Twin Cities ...
(Date:12/19/2014)... Today, Balfleet.com , a leading ... its formal dress promotion. All the old and new ... off. , Balfleet.com is well-known for its high quality ... dresses, cocktail dresses and more. Its formal dresses are ... and they can create an elegant look when paired ...
(Date:12/19/2014)... Sub Zero Ice Cream is partnering up with ... the 28th from 2pm-6pm at the Expo Center on the ... FL. , Inquiries regarding time slots and signing up, email ... donating process, Sub Zero Ice Cream & Yogurt will be ... , About Sub Zero Ice Cream & Yogurt , ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 2Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 3Health News:Risperdal Lawsuit News: Bernstein Liebhard LLP Notes Publication of Study Suggesting Medication May Raise Prolactin Levels in Children 4Health News:AngelWeddingDress Has Introduced Its Special Offer For The Coming Christmas 2Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Shark Tank’s Sub Zero Ice Cream Sponsors Blood Drive 2
... by Professor Richard Hayes at the London School of ... to test an innovative combination of strategies to prevent ... ART (PopART), will test the impact of a combination ... HIV, offer of medical circumcision to men who test ...
... symposium will provide information to educate physicians, psychiatrists ... the possibility of neurological repercussions to post-infectious syndromes. ... known about the cause and effect relationship between ... this symposium will raise the medical community,s awareness ...
... (HealthDay News) -- The facts about cancer found on ... information on the disease found on the patient-oriented section ... (PDQ), a comprehensive peer-reviewed cancer database, according to a ... University were hard-pressed to find errors on Wikipedia, they ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, Sept. ... will begin earlier this year, so seniors need to ... they want in 2012, U.S. health officials said Thursday. ... the same for the 99.7 percent of Medicare recipients who ...
... A new study suggests that blocking cancer cells, access ... glioblastoma, the most common and deadly form of brain ... be appropriate for tumors with a hyperactive PI3K signaling ... glioblastomas cases. , Researchers at the Ohio State University ...
... rare but often deadly disease that can strike at any ... women and in the past was referred to as a ... with ovarian cancer that can assist in early detection. Experts ... use of preventive methods, understand the risks and recognize potential ...
Cached Medicine News:Health News:Major grant awarded for HIV prevention study in Africa 2Health News:Major grant awarded for HIV prevention study in Africa 3Health News:Wikipedia Accurate on Cancer Facts, But Hard to Read: Study 2Health News:Enrollment Period for Medicare Starts Early This Year 2Health News:Starving cancer cells of cholesterol might offer a new way to treat brain tumors 2Health News:Early detection is key in the fight against ovarian cancer 2Health News:Early detection is key in the fight against ovarian cancer 3
... The ROYAL™ single-use skin stapler places one ... The staples first penetrate the skin and are ... skin staples are available in two sizes: wide ... closure) and regular (having a clip span of ...
... CONCORDE staplers place one staple ... are activated. The staples first ... then formed, thus holding the ... staple sizes, each contained in ...
... PROXIMATE Skin Staplers place single ... are made of lubricant-coated stainless steel; ... Endo-Surgery makes three different skin staplers ... skin stapler has applications for routine ...
... articulating (22° and 45° in both directions) ... resection, transection and anastomosis for open surgery ... two triple-staggered rows of staples and simultaneously ... The instrument is designed for multiple use ...
Medicine Products: